| Virtua Home Care - Community Nursing Services | |
| 523 Fellowship Road - Suite 250, Mount Laurel, New Jersey 8054 | |
| (856) 581-7200 | |
| Name | Virtua Home Care - Community Nursing Services |
|---|---|
| Location | 523 Fellowship Road - Suite 250, Mount Laurel, New Jersey |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 317035 |
| Ownership Type | Voluntary Non-profit - Private |
| Service Area Zip Codes | 8002, 8010, 8011, 8015, 8016, 8019, 8022, 8036, 8041, 8042, 8046, 8048, 8052, 8053, 8054, 8055, 8057, 8060, 8064, 8065, 8068, 8073, 8075, 8077, 8088, 8501, 8505, 8511, 8515, 8518, 8554, 8562, 8610, 8620, 8641 |
| NPI Number | 1922004613 |
| Organization Name | VIRTUA - MEMORIAL HOSPITAL OF BURLINGTON COUNTY, INC. |
| Doing Business As | VIRTUA HOMECARE COMMUNITY NURSING SERVICES |
| Address | 523 Fellowship Rd, Ste 250, Mount Laurel, NJ 08054 |
| Phone Number | 856-581-7200 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.
Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
How can successful companies use lifelong learning to have a competitive advantage in their enterprises? This is one of the questions being addressed by the new LLLight'in'Europe project, which wants to analyse the importance of lifelong learning activities to ensure better person to job fits.
› Verified 9 days ago
| Quality Rating: |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.
Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
How can successful companies use lifelong learning to have a competitive advantage in their enterprises? This is one of the questions being addressed by the new LLLight'in'Europe project, which wants to analyse the importance of lifelong learning activities to ensure better person to job fits.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 92.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 97.8 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.6 | 99.6 |
| How often the home health team checked patients for depression | 99 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 80.9 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 89.1 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.6 | 96.4 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.
Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
How can successful companies use lifelong learning to have a competitive advantage in their enterprises? This is one of the questions being addressed by the new LLLight'in'Europe project, which wants to analyse the importance of lifelong learning activities to ensure better person to job fits.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 75.2 | 79.6 |
| How often patients got better at getting in and out of bed | 83.3 | 81.1 |
| How often patients got better at bathing | 76 | 82.3 |
| How often patients’ breathing improved | 85.5 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 85.5 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 69.6 | 75 |
| How often home health patients had to be admitted to the hospital | 18.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 9.5 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 91.8 | 94 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.
Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
How can successful companies use lifelong learning to have a competitive advantage in their enterprises? This is one of the questions being addressed by the new LLLight'in'Europe project, which wants to analyse the importance of lifelong learning activities to ensure better person to job fits.
› Verified 9 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.
Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
How can successful companies use lifelong learning to have a competitive advantage in their enterprises? This is one of the questions being addressed by the new LLLight'in'Europe project, which wants to analyse the importance of lifelong learning activities to ensure better person to job fits.
› Verified 9 days ago
The patient survey data of Virtua Home Care - Community Nursing Services is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 88 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 88 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 79 | 78 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.
Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
How can successful companies use lifelong learning to have a competitive advantage in their enterprises? This is one of the questions being addressed by the new LLLight'in'Europe project, which wants to analyse the importance of lifelong learning activities to ensure better person to job fits.
› Verified 9 days ago
Virtua Home Care - Community Nursing Services Location: 523 Fellowship Road - Suite 250, Mount Laurel, New Jersey 8054 Ratings: Phone: (856) 581-7200 | |
Virtua Home Care At West Jersey Location: 523 Fellowship Road, Suite 250, Mount Laurel, New Jersey 8054 Ratings: Phone: (856) 581-7200 |